Entry Detail



General Information

Database ID:exR0090112
RNA Name:hsa-miR-520d-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):53720149End Site(bp):53720170
External Links:hsa-miR-520d-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
CAMK2N1
chr1
20482391
20486210
-
KIAA1522
chr1
32741830
32774970
+
RGMA
chr15
93035273
93089204
-
APP
chr21
25880550
26171128
-
ATP6V1B2
chr8
20197381
20226819
+
CUL1
chr7
148697914
148801110
+
WASF3
chr13
26557683
26688948
+
ATP6V1C1
chr8
103021063
103073051
+
FYCO1
chr3
45917899
45995824
-
DIP2A
chr21
46458891
46570015
+
LONP2
chr16
48244300
48363122
+
ARL4A
chr7
12686856
12690958
+
ZSCAN26
chr6
28267010
28278224
+
PLAGL2
chr20
32192504
32207743
-
MLLT1
chr19
6210381
6279975
-
SRRT
chr7
100875103
100888664
+
AMPD2
chr1
109616104
109632053
+
GLCE
chr15
69160584
69272217
+
ZFAND4
chr10
45615500
45672780
-
MTF1
chr1
37809574
37859592
-
FAM102A
chr9
127940582
127980989
-
CCDC93
chr2
117915478
118014133
-
VLDLR
chr9
2621787
2660056
+
ATXN1
chr6
16299112
16761491
-
PHC3
chr3
170086732
170181749
-
CELF2
chr10
10798397
11336675
+
SCAMP2
chr15
74843730
74873365
-
SEMA3C
chr7
80742538
80922359
-
CHD9
chr16
53055033
53329150
+
MNT
chr17
2384073
2401104
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.